IL-21 variants

Details for Australian Patent Application No. 2007310777 (hide)

Owner Novo Nordisk A/S

Inventors Hjorth, Siv Annegrethe; Bodensgaard, Kent; Madsen, Dennis

Agent Spruson & Ferguson

Pub. Number AU-A-2007310777

PCT Pub. Number WO2008/049920

Priority 06123040.5 26.10.06 EP

Filing date 26 October 2007

Wipo publication date 2 May 2008

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

C07K 14/45 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/049920 Priority application(s): WO2008/049920

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007310787-A method for profiling kinase inhibitors

2007310770-Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them